• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默型痴呆患者脑脊液中乙酰胆碱浓度显著降低。

Remarkable reduction in acetylcholine concentration in the cerebrospinal fluid from patients with Alzheimer type dementia.

作者信息

Tohgi H, Abe T, Hashiguchi K, Saheki M, Takahashi S

机构信息

Department of Neurology, Iwate Medical University, Morioka, Japan.

出版信息

Neurosci Lett. 1994 Aug 15;177(1-2):139-42. doi: 10.1016/0304-3940(94)90064-7.

DOI:10.1016/0304-3940(94)90064-7
PMID:7824166
Abstract

We determined the concentrations of acetylcholine (ACh) and choline (Ch) in the cerebrospinal fluid (CSF) of patients with Alzheimer type dementia (ATD) in comparison with controls. The ACh concentration was reduced significantly and remarkably (73%, P < 0.0002) in ATD patients and had a significant positive correlation with dementia scale scores (r = 0.82, P < 0.05). The Ch concentration was unaltered in ATD patients. These results suggest that the progressive reduction in ACh in the ATD brain may be reflected in its concentrations in the CSF.

摘要

我们测定了阿尔茨海默型痴呆(ATD)患者脑脊液(CSF)中乙酰胆碱(ACh)和胆碱(Ch)的浓度,并与对照组进行比较。ATD患者的ACh浓度显著降低(73%,P < 0.0002),且与痴呆量表评分呈显著正相关(r = 0.82,P < 0.05)。ATD患者的Ch浓度未发生改变。这些结果表明,ATD大脑中ACh的逐渐减少可能反映在CSF中的浓度上。

相似文献

1
Remarkable reduction in acetylcholine concentration in the cerebrospinal fluid from patients with Alzheimer type dementia.阿尔茨海默型痴呆患者脑脊液中乙酰胆碱浓度显著降低。
Neurosci Lett. 1994 Aug 15;177(1-2):139-42. doi: 10.1016/0304-3940(94)90064-7.
2
Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia.
J Neural Transm (Vienna). 1996;103(10):1211-20. doi: 10.1007/BF01271206.
3
Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia.阿尔茨海默病和血管性痴呆患者脑脊液中乙酰胆碱和胆碱浓度的差异
Chin Med J (Engl). 2004 Aug;117(8):1161-4.
4
Changes of acetylcholine and choline concentrations in cerebrospinal fluids of normal subjects and patients with dementia of Alzheimer-type.
J Neural Transm Suppl. 1990;30:25-32. doi: 10.1007/978-3-7091-3345-3_3.
5
Acetylcholine in human CSF: methodological considerations and levels in dementia of Alzheimer type.人脑脊液中的乙酰胆碱:方法学考量及阿尔茨海默型痴呆中的水平
J Neural Transm (Vienna). 1998;105(8-9):961-73. doi: 10.1007/s007020050105.
6
Cerebrospinal fluid acetylcholine, choline, and senile dementia of the Alzheimer's type.脑脊液乙酰胆碱、胆碱与阿尔茨海默型老年痴呆症
Psychopharmacol Bull. 1982 Oct;18(4):193-5.
7
Acetylcholine and choline in cerebrospinal fluid of patients with Parkinson's disease and Huntington's chorea.帕金森病和亨廷顿舞蹈症患者脑脊液中的乙酰胆碱和胆碱
J Neurol Neurosurg Psychiatry. 1976 Apr;39(4):367-74. doi: 10.1136/jnnp.39.4.367.
8
Choline levels are increased in cerebrospinal fluid of Alzheimer patients.阿尔茨海默病患者脑脊液中的胆碱水平升高。
Neurobiol Aging. 1989 Jan-Feb;10(1):45-50. doi: 10.1016/s0197-4580(89)80009-0.
9
The urate and xanthine concentrations in the cerebrospinal fluid in patients with vascular dementia of the Binswanger type, Alzheimer type dementia, and Parkinson's disease.宾斯万格型血管性痴呆、阿尔茨海默型痴呆和帕金森病患者脑脊液中的尿酸盐和黄嘌呤浓度。
J Neural Transm Park Dis Dement Sect. 1993;6(2):119-26. doi: 10.1007/BF02261005.
10
CSF choline and acetylcholinesterase in early-onset vs. late-onset Alzheimer's disease patients.早发型与晚发型阿尔茨海默病患者脑脊液中的胆碱和乙酰胆碱酯酶
Acta Neurol Scand. 1989 Nov;80(5):461-6. doi: 10.1111/j.1600-0404.1989.tb03910.x.

引用本文的文献

1
Triple-Target Inhibition of Cholinesterase, Amyloid Aggregation, and GSK3β to Ameliorate Cognitive Deficits and Neuropathology in the Triple-Transgenic Mouse Model of Alzheimer's Disease.三重靶向抑制胆碱酯酶、淀粉样蛋白聚集和糖原合成酶激酶3β以改善阿尔茨海默病三重转基因小鼠模型中的认知缺陷和神经病理学
Neurosci Bull. 2025 May;41(5):821-836. doi: 10.1007/s12264-025-01354-y. Epub 2025 Feb 5.
2
Unraveling the Molecular Landscape of SCN1A Gene Knockout in Cerebral Organoids: A Multiomics Approach Utilizing Proteomics, Lipidomics, and Transcriptomics.解析脑类器官中SCN1A基因敲除的分子图谱:一种利用蛋白质组学、脂质组学和转录组学的多组学方法
ACS Omega. 2024 Sep 13;9(38):39804-39816. doi: 10.1021/acsomega.4c05039. eCollection 2024 Sep 24.
3
Succinimide Derivatives as Acetylcholinesterase Inhibitors-In Silico and In Vitro Studies.
琥珀酰亚胺衍生物作为乙酰胆碱酯酶抑制剂的计算机模拟和体外研究
Curr Issues Mol Biol. 2024 May 22;46(6):5117-5130. doi: 10.3390/cimb46060307.
4
Cholinergic Antagonists and Behavioral Disturbances in Neurodegenerative Diseases.胆碱能拮抗剂与神经退行性疾病中的行为障碍。
Int J Mol Sci. 2023 Apr 7;24(8):6921. doi: 10.3390/ijms24086921.
5
The Brilliance of the Zebrafish Model: Perception on Behavior and Alzheimer's Disease.斑马鱼模型的卓越之处:对行为与阿尔茨海默病的认知
Front Behav Neurosci. 2022 Jun 13;16:861155. doi: 10.3389/fnbeh.2022.861155. eCollection 2022.
6
In Vitro and In Silico Kinetic Studies of Patented 1,7-diEthyl and 1,7-diMethyl Aminoalkanol Derivatives as New Inhibitors of Acetylcholinesterase.专利的 1,7-二乙基和 1,7-二甲基氨基烷醇衍生物作为乙酰胆碱酯酶新抑制剂的体外和计算动力学研究。
Int J Mol Sci. 2021 Dec 27;23(1):270. doi: 10.3390/ijms23010270.
7
Evaluation of Metabolic and Synaptic Dysfunction Hypotheses of Alzheimer's Disease (AD): A Meta-Analysis of CSF Markers.阿尔茨海默病(AD)代谢和突触功能障碍假说的评估:脑脊液标志物的荟萃分析
Curr Alzheimer Res. 2018;15(2):164-181. doi: 10.2174/1567205014666170921122458.
8
Evaluation of Cholinergic Deficiency in Preclinical Alzheimer's Disease Using Pupillometry.使用瞳孔测量法评估临床前阿尔茨海默病中的胆碱能缺乏
J Ophthalmol. 2017;2017:7935406. doi: 10.1155/2017/7935406. Epub 2017 Aug 16.
9
Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.阿尔茨海默病中的线粒体功能障碍与突触传递失败
J Alzheimers Dis. 2017;57(4):1071-1086. doi: 10.3233/JAD-160702.
10
Cholinergic Enhancement of Cell Proliferation in the Postnatal Neurogenic Niche of the Mammalian Spinal Cord.胆碱能增强哺乳动物脊髓出生后神经发生微环境中的细胞增殖
Stem Cells. 2015 Sep;33(9):2864-76. doi: 10.1002/stem.2077. Epub 2015 Jun 26.